How will the LORETTA and COMET trials influence your treatment of low-risk DCIS?  

The COMET and LORETTA trials were designed to address whether women with low-risk DCIS can safely be treated without surgery. The endpoint of both trials was ipsilateral invasive cancer. The COMET trial randomized 995 women to receive guideline-concordant care (surgery ± radiation) vs active ...